Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-05-22FDA Approved: RIFAMPIN — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for rifampin from Mylan Institutional LLC, enabling a generic rifampin product. This action approves th…
-
CLINICAL_TRIALS trial_result · 2008-04-25Clinical Trial Update: Tuberculosis Immunity in Children
This update indicates the clinical trial evaluating immunity to tuberculosis in children has completed. The sponsor is the National Institut…
-
CLINICAL_TRIALS trial_result · 2008-04-16Clinical Trial Update: Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease [Phase 4]
Phase 4 trial update comparing the Quantiferon-TB Gold assay with tuberculin skin testing in patients with chronic liver disease, including …
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine [Phase 1]
Phase 1 study from the University of Oxford evaluates the safety and immunogenicity of the Bacille Calmette-Guérin (BCG) vaccine in tubercul…
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG [Phase 1]
A Phase 1 study evaluating two doses of the TB vaccine MVA85A in healthy volunteers previously vaccinated with BCG.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
This completed clinical trial evaluated the safety and potential efficacy of intravitreal bevacizumab for recalcitrant inflammatory ocular n…
-
FDA approval · 2008-03-28FDA Approved: RIFAMPIN — Original Application (Chartwell RX, LLC)
FDA approved an Original Application (ANDA) for rifampin submitted by Chartwell RX, LLC. This marks approval of a generic rifampin product.
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis
The document reports results from a completed clinical trial evaluating an interferon-gamma release assay after treatment for tuberculosis.
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion [NA]
A completed clinical trial evaluating the use of continuous positive airway pressure in patients with tuberculosis pleural effusion.
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area
The completed trial evaluated the use of a gamma interferon assay for contact tracing in tuberculosis in a low-incidence, high-immigration a…
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: Follow up of Autoantibodies in Active Tuberculosis
This clinical trial update reports on follow-up data regarding autoantibodies in patients with active tuberculosis.
-
CLINICAL_TRIALS research · 2007-10-24Clinical Trial Update: Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care [NA]
This clinical trial update examines the impact of a public-sector antiretroviral treatment program on tuberculosis and immunization care. It…
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Tuberculosis in HIV Infected Patients in Uganda [Phase 2]
A Phase 2 trial evaluating tuberculosis treatment in HIV-infected individuals in Uganda has completed.
-
CLINICAL_TRIALS research · 2007-06-26Clinical Trial Update: Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists [NA]
This clinical trial update concerns using QuantiFERON-TB Gold to assess latent tuberculosis in patients with rheumatoid arthritis or spondyl…
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB. [Phase 1]
Phase 1 trial update reporting on safety and immunogenicity of the MVA85A TB vaccine in volunteers latently infected with tuberculosis.
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers [Phase 1]
The University of Oxford conducted a Phase 1 study to evaluate the immunogenicity of intradermal Mycobacterium bovis BCG in healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers [NA]
An update on a completed study evaluating the immunogenicity of intradermal Bacille Calmette-Guérin (BCG) vaccine in healthy volunteers.
-
CLINICAL_TRIALS research · 2007-04-05Clinical Trial Update: Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
A clinical trial update examining the use of interferon-gamma release assays to diagnose active and latent tuberculosis infection in African…
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Phase 2]
A Phase 2 trial comparing moxifloxacin to ethambutol for treatment of pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-12Clinical Trial Update: Food Incentives for TB Treatment Compliance in East Timor (FITTCET) [NA]
This clinical trial evaluated whether providing food incentives improves tuberculosis treatment adherence in East Timor; the study has compl…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG [Phase 1]
A Phase I trial evaluated the safety and immunogenicity of a recombinant MVA-based vaccine encoding Mycobacterium tuberculosis antigen 85A, …
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously [Phase 1]
Phase 1 study assessing safety and immunogenicity of a recombinant MVA vaccine encoding antigen 85A (MVA-85A) delivered intradermally in hea…
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. [Phase 1]
Phase I study evaluating safety and immunogenicity of a recombinant MVA vaccine encoding antigen 85A for tuberculosis, delivered intradermal…
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers [Phase 1]
Phase I trial assessing safety and immunogenicity of the MVA85A TB vaccine in healthy Gambian volunteers has been completed. The study evalu…
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [Phase 4]
A Phase 4 trial comparing three regimens for chemoprophylaxis of tuberculosis in patients co-infected with HIV has completed.